The intrarenal blood flow distribution and role of nitric oxide in diabetic rats

• Published in: Metabolism, clinical and experimental Vol. 54; no. 6; pp. 788 - 792
• Main Authors: Nakanishi, Kazushige, Onuma, Shizuka, Higa, Mariko, Nagai, Yohko, Inokuchi, Toshiki
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.06.2005; Elsevier
• Subjects: Animals; Biological and medical sciences; Blood Pressure; Diabetes Mellitus, Experimental - physiopathology; Diabetes. Impaired glucose tolerance; Diabetic Nephropathies - physiopathology; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Kidneys; Male; Medical sciences; Nephrology. Urinary tract diseases; NG-Nitroarginine Methyl Ester - pharmacology; Nitric Oxide - physiology; Rats; Rats, Sprague-Dawley; Renal Circulation; Streptozocin; Urinary system involvement in other diseases. Miscellaneous; Endocrinopathy; Antineoplastic agent; Doppler ultrasound study; Renal artery; Rat; Fiber laser; Outer; Diabetic nephropathy; Streptozotocin; Sonography; Kidney disease; Regional blood flow; Urinary system disease; Implant; Diabetes mellitus; Rodentia; Injection; Intrarenal; Blood flow; Flow; Vertebrata; Antibiotic; Ultrasonic probe; Mammalia; Urinary system; Implanted; Aminoacid; Animal; Nitric oxide; Distribution; Hemodynamics; Technique; Renal cortex
• ISSN: 0026-0495; 1532-8600
• DOI: 10.1016/j.metabol.2005.01.023

A few attempts have so far been made to determine the regional renal blood flow distribution in experimental diabetic rats. In the present experiment, 3 weeks after successful streptozotocin injection in diabetic rats (n = 8), the blood flows in the renal superficial and deep cortexes and outer medulla with implanted fibers were measured by laser-Doppler techniques. Renal blood flow was measured by an ultrasonic flow probe placed around the renal artery. Studies were performed at the baseline condition, during the administration of nonselective nitric oxide synthesis inhibitor, nitro- l-arginine methyl-ester ( l-NAME), and during the postinfusion period. The results showed that superficial cortical blood flow and deep cortical blood flow were significantly greater ( P < .05) in diabetic rats compared with control rats (n = 8) (superficial cortical blood flow, 2.18 ± 0.22 vs 1.55 ± 0.21 V; deep cortical blood flow, 1.32 ± 0.13 vs 0.99 ± 0.14 V) with the significant increase in renal blood flow (18.1 ± 3.3 vs 14.5 ± 2.7 mL/min). Furthermore, it was shown that in diabetic rats the intravenous infusion of a low dose of l-NAME, which did not alter medullary blood flow, decreased cortical blood flow (CBF) ( P < .05), whereas in control rats l-NAME did not affect CBF but a high dose of l-NAME decreased medullary blood flow ( P < .05). We conclude that in early diabetic nephropathy the blood flow is increased in both the superficial and deep cortexes, and nitric oxide plays an important role in regulating the CBF during the development of diabetic nephropathy.